How Viagra revolutionized the erectile dysfunction market
The erectile dysfunction market isn’t as lucrative as it once was, but that hasn’t mattered much to Pfizer. The New York-based pharmaceutical giant is holding a strong share in the ED drug marketplace even as competition from generic drugmakers consumes sales of its once-blockbuster male libido treatment, Viagra. The medication, originally developed with the intention… Read More »